Sentences with phrase «median survival time with»

Median survival time with amputation and chemotherapy is 9 - 11 months3 - 4.

Median survival time with surgery and chemotherapy ranges from 7 to 12 months.

Median survival time with surgery alone or palliative radiation therapy is 4 to 5 months.

Brahmer emphasizes that the relatively small increase in median survival time with the use of the new immunotherapy drugs may be somewhat misleading in terms of overall impact of the medicines.

Not exact matches

The infection is virtually always fatal, with a median survival time after the onset of symptoms of four days.

Of the dogs stricken with osteosarcoma, 35 had the cancer in a leg which was subsequently amputated, followed by chemotherapy, which is the standard - of - care treatment; the dogs with elevated total cholesterol had a median survival time of 455 days, more than 200 days greater than the median survival time for dogs with normal cholesterol.

With standard treatments of surgery, chemotherapy and radiation, the median survival time is only 14.6 months, and improvement will only come with the ability to kill tumor cells resistant to standard treatments, according to Alfredo Quiñones - Hinojosa, M.D., a professor of neurosurgery at the Johns Hopkins University School of Medicine and a member of the research tWith standard treatments of surgery, chemotherapy and radiation, the median survival time is only 14.6 months, and improvement will only come with the ability to kill tumor cells resistant to standard treatments, according to Alfredo Quiñones - Hinojosa, M.D., a professor of neurosurgery at the Johns Hopkins University School of Medicine and a member of the research twith the ability to kill tumor cells resistant to standard treatments, according to Alfredo Quiñones - Hinojosa, M.D., a professor of neurosurgery at the Johns Hopkins University School of Medicine and a member of the research team.

The therapy has greatly helped the majority of the patients, most of whom had undergone heavy treatments before and had prognoses with a median survival time (without the TAT therapy) of 2 - 4 months.

The team found that patients with more varied types of bacteria in their digestive tract had longer median progression - free survival, defined at the time point where half of studied patients have their disease progress.

The researchers then tested their scoring method using data on 688 AML patients in three different clinical trials, In each of these groups, patients with low scores (methylation patterns similar to normal HSCs) had approximately twice the median survival time of patients with high scores.

At five years, 34 of the 102 patients had achieved a complete response (disappearance of their cancer for a period of time), with an estimated 64 percent of patients surviving with or without disease (median five - year overall survival was 40.5 months) and an estimated 52 percent surviving without disease progression.

Sweeney said more time is needed to assess the benefit of the drug combination in the men with lesser burdens of disease, as their median survival has not yet been reached.

The tumors grew rapidly in the control experiments (the median time for tumor - free survival was one week) and any differences in tumor - free survival for the controls and the mice injected with cells expressing mutated PREX2 were not statistically significant (Horrigan et al., 2017).

In one study, median survival time was 118 days for dogs with evidence of tumor invasion of other local organs compared with 218 days for dogs with no evidence of invasion beyond the urinary bladder.

In general, dogs with meningiomas have a median survival time of 1 - 2 years.

The median survival time for most dogs on chemotherapy is approximately one year with 25 % of dogs surviving two years.

The median survival time for dogs with severe SAS who do not receive treatment is 19 months.

Stage 3 oral melanomas have reported median survival times of approximately six months with treatment.

With chemotherapy treatments, total remission is approximately 60 - 90 % of cases with a median survival time of 6 - 12 monWith chemotherapy treatments, total remission is approximately 60 - 90 % of cases with a median survival time of 6 - 12 monwith a median survival time of 6 - 12 months.

According to the Ohio State University Veterinary Medical Center's webpage on mammary cancer, cats with tumors more than 3 cm in diameter have a median survival time of 4 to 6 months, cats with tumors 2 to 3 cm in diameter have a typical life expectancy of about two years, and cats with tumors less than 2 cm in diameter generally survive more than three years.

Prognosis — Conventional chemotherapy results in total remission in approximately 60 - 90 % of cases with a median survival time of 6 - 12 months.

The median survival time for a cat diagnosed with FIV is approximately five years.

With prednisone alone, median survival times noted are approximately 75 - 90 days.

Monitoring for bone marrow suppression is needed with a medication this strong, but in one study with 10 affected dogs all were able to achieve remission and median survival time was 531 days.

The important factors that tend to predict prognosis are the size of tumors (dogs with tumors greater than 10.7 cm2 had median survivals of 9.7 months vs. 19 months for tumors smaller than 10.7 cm2) and hypercalcemia (patients with elevated calcium levels had median survival times of 8.5 months vs. 19.5 for patients with normal calcium levels).

As a group, dogs with stage I - III have a median survival time of 323 days.

Dogs with tumors less than or equal to 3 cm in diameter prior to surgery had a median survival time of 31 months.

Cats treated with a multidrug chemotherapy protocol have a median survival time of 7 months; however some cats that achieve complete remission can live longer.

Dogs treated with a multi-drug chemotherapy protocol have a median survival time of one year with 25 percent of dogs living to 2 years.

Even with surgery and chemotherapy, the median survival time remains only 10 - 12 months.

Cats with advanced lung involvement at the time the tumor is diagnosed have a median survival time of only one month.

«Prior to this, the longest reported median survival time of dogs with hemangiosarcoma of the spleen that underwent no further treatment was 86 days.

Recently, a median survival time of 7 months was reported for dogs receiving radiation therapy along with chemotherapy; whereas a combination of surgery and chemotherapy showed more encouraging median survival rates of 235 - 366 days with up to 28 % surviving two years after diagnosis.

Six dogs with splenic hemangiosarcoma received ifosfamide postsplenectomy and their median survival time was 147 days.

Median survival time after surgery alone is reported to be 2 - 3 months, with the addition of chemotherapy increasing the median survival time to 4 - 6 mMedian survival time after surgery alone is reported to be 2 - 3 months, with the addition of chemotherapy increasing the median survival time to 4 - 6 mmedian survival time to 4 - 6 months.

Prognosis — The median survival time of dogs suffering from nasal chondrosarcoma and treated with rhinotomy is 1 - 2 years.

Dogs with tumors less than 2 cm have median survival times of greater than 68 months overall when treated with surgery with wide margins.

Prognosis is variable, and the median survival time is reported to be 563 days for cats with heart failure.

Median survival time for dogs with nosebleeds was 88 days vs. 224 days for dogs with carcinomas that did not have nose bleeds.

According to some reports, dogs treated with system chemotherapy showed a median survival time of 5 months to 31 months.